- Home
- IMCC vs EVGN Comparison
IMCC vs EVGN Comparison
Compare IMCC & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- EVGN
- Stock Information
- Founded
- IMCC 1980
- EVGN 1999
- Country
- IMCC Israel
- EVGN Israel
- Employees
- IMCC N/A
- EVGN N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- EVGN Agricultural Chemicals
- Sector
- IMCC Health Care
- EVGN Industrials
- Exchange
- IMCC Nasdaq
- EVGN Nasdaq
- Market Cap
- IMCC 10.4M
- EVGN 10.9M
- IPO Year
- IMCC N/A
- EVGN N/A
- Fundamental
- Price
- IMCC $1.32
- EVGN $1.16
- Analyst Decision
- IMCC
- EVGN Strong Buy
- Analyst Count
- IMCC 0
- EVGN 1
- Target Price
- IMCC N/A
- EVGN $3.50
- AVG Volume (30 Days)
- IMCC 1.3M
- EVGN 48.6K
- Earning Date
- IMCC 11-13-2025
- EVGN 11-20-2025
- Dividend Yield
- IMCC N/A
- EVGN N/A
- EPS Growth
- IMCC N/A
- EVGN N/A
- EPS
- IMCC N/A
- EVGN N/A
- Revenue
- IMCC $37,606,703.00
- EVGN $9,444,000.00
- Revenue This Year
- IMCC $47.12
- EVGN N/A
- Revenue Next Year
- IMCC $12.83
- EVGN $12.35
- P/E Ratio
- IMCC N/A
- EVGN N/A
- Revenue Growth
- IMCC 1.92
- EVGN 42.25
- 52 Week Low
- IMCC $0.93
- EVGN $0.95
- 52 Week High
- IMCC $7.12
- EVGN $2.42
- Technical
- Relative Strength Index (RSI)
- IMCC 43.09
- EVGN 41.26
- Support Level
- IMCC $0.93
- EVGN $1.15
- Resistance Level
- IMCC $1.54
- EVGN $1.25
- Average True Range (ATR)
- IMCC 0.16
- EVGN 0.06
- MACD
- IMCC 0.01
- EVGN -0.01
- Stochastic Oscillator
- IMCC 60.33
- EVGN 17.69
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.